Evidence map›Paper›PMID 23991149›Full record

ArticlePloS one2013

Investigating the consequences of eIF4E2 (4EHP) interaction with 4E-transporter on its cellular distribution in HeLa cells.

Dorota Kubacka, Anastasiia Kamenska, Helen Broomhead, Nicola Minshall, Edward Darzynkiewicz, Nancy Standart

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Eukaryotic mRNA Decapping Activation.Frontiers in genetics · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cap-binding protein 4EHP effects translation silencing by microRNAs.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. Distinct features of cap binding by eIF4E1b proteins.Journal of molecular biology · 2015
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Dorota KubackaDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Anastasiia Kamenska
Helen Broomhead
Nicola Minshall
Edward Darzynkiewicz
Nancy Standart
University of Cambridge · GBUniversity of Warsaw · PL

Funding

Wellcome TrustWellcome Trust 084885/Z/08/Z
6 · The paper itself

Abstract

In addition to the canonical eIF4E cap-binding protein, eukaryotes have evolved sequence-related variants with distinct features, some of which have been shown to negatively regulate translation of particular mRNAs, but which remain poorly characterised. Mammalian eIF4E proteins have been divided into three classes, with class I representing the canonical cap-binding protein eIF4E1. eIF4E1 binds eIF4G to initiate translation, and other eIF4E-binding proteins such as 4E-BPs and 4E-T prevent this interaction by binding eIF4E1 with the same consensus sequence YX 4Lϕ. We investigate here the interaction of human eIF4E2 (4EHP), a class II eIF4E protein, which binds the cap weakly, with eIF4E-transporter protein, 4E-T. We first show that ratios of eIF4E1:4E-T range from 50:1 to 15:1 in HeLa and HEK293 cells respectively, while those of eIF4E2:4E-T vary from 6:1 to 3:1. We next provide evidence that eIF4E2 binds 4E-T in the yeast two hybrid assay, as well as in pull-down assays and by recruitment to P-bodies in mammalian cells. We also show that while both eIF4E1 and eIF4E2 bind 4E-T via the canonical YX 4Lϕ sequence, nearby downstream sequences also influence eIF4E:4E-T interactions. Indirect immunofluorescence was used to demonstrate that eIF4E2, normally homogeneously localised in the cytoplasm, does not redistribute to stress granules in arsenite-treated cells, nor to P-bodies in Actinomycin D-treated cells, in contrast to eIF4E1. Moreover, eIF4E2 shuttles through nuclei in a Crm1-dependent manner, but in an 4E-T-independent manner, also unlike eIF4E1. Altogether we conclude that while both cap-binding proteins interact with 4E-T, and can be recruited by 4E-T to P-bodies, eIF4E2 functions are likely to be distinct from those of eIF4E1, both in the cytoplasm and nucleus, further extending our understanding of mammalian class I and II cap-binding proteins.

Indexed as

Amino Acid SequenceAnimalsBlotting, WesternElectrophoresis, Polyacrylamide GelEukaryotic Initiation Factor-4EHEK293 CellsHeLa CellsHumansMolecular Sequence DataNucleocytoplasmic Transport ProteinsProtein BindingRNA Cap-Binding ProteinsSequence Homology, Amino AcidTwo-Hybrid System TechniquesXenopusEIF4E2 protein, humanEIF4ENIF1 protein, humanEukaryotic Initiation Factor-4ENucleocytoplasmic Transport ProteinsRNA Cap-Binding Proteins

Identifiers

PMID23991149
PMCPMC3749138
OpenAlexW2081240376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.